TrialGynecologic oncology2019

Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.

Antonio González Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.